Kiniksa Pharmaceuticals, Ltd.
NASDAQ:KNSA
22.16 (USD) • At close March 13, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 423.239 | 270.259 | 220.18 | 38.544 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 0 | 56.524 | 46.966 | 9.1 | 3.805 | 3.279 | 0.286 | 0.028 | 0.022 |
| Gross Profit
| 423.239 | 213.735 | 173.214 | 29.444 | -3.805 | -3.279 | -0.286 | -0.028 | -0.022 |
| Gross Profit Ratio
| 1 | 0.791 | 0.787 | 0.764 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 111.623 | 76.097 | 65.49 | 99.297 | 112.042 | 135.001 | 86.597 | 56.357 | 17.439 |
| General & Administrative Expenses
| 0 | 0 | 0 | 0 | 0 | 34.962 | 21.563 | 9.043 | 6.563 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 168.011 | 129.427 | 97.951 | 85.948 | 45.321 | 34.962 | 21.563 | 9.043 | 6.563 |
| Other Expenses
| 189.221 | 33.407 | 1.253 | 0.835 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 468.855 | 238.931 | 163.441 | 186.08 | 157.363 | 169.963 | 108.16 | 65.4 | 24.002 |
| Operating Income
| -45.616 | -25.196 | 7.371 | -156.636 | -157.363 | -169.963 | -108.16 | -65.4 | -24.002 |
| Operating Income Ratio
| -0.108 | -0.093 | 0.033 | -4.064 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| 9.464 | 8.544 | 1.253 | 0.097 | 1.134 | 6.049 | 4.719 | 0.529 | 0.065 |
| Income Before Tax
| -36.152 | -16.652 | 11.026 | -156.539 | -156.229 | -163.914 | -103.441 | -64.871 | -23.937 |
| Income Before Tax Ratio
| -0.085 | -0.062 | 0.05 | -4.061 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| 7.041 | -30.736 | -172.337 | 1.385 | 5.152 | -2.047 | -0.214 | 0.002 | 0.036 |
| Net Income
| -43.193 | 14.084 | 183.363 | -157.924 | -161.381 | -161.867 | -103.227 | -64.873 | -23.973 |
| Net Income Ratio
| -0.102 | 0.052 | 0.833 | -4.097 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.6 | 0.2 | 2.64 | -2.3 | -2.61 | -2.99 | -3.49 | -2 | -0.74 |
| EPS Diluted
| -0.6 | 0.2 | 2.6 | -2.3 | -2.61 | -2.99 | -3.49 | -2 | -0.74 |
| EBITDA
| -45.616 | -22.855 | 9.773 | -154.281 | -152.424 | -167.895 | -107.874 | -65.372 | -23.98 |
| EBITDA Ratio
| -0.108 | -0.085 | 0.044 | -4.064 | 0 | 0 | 0 | 0 | 0 |